Warburg Research Analysts Give Bayer (BAYN) a €88.50 Price Target

Bayer (FRA:BAYN) has been given a €88.50 ($102.91) target price by research analysts at Warburg Research in a research note issued on Thursday. The firm currently has a “buy” rating on the healthcare company’s stock. Warburg Research’s target price indicates a potential upside of 16.29% from the company’s current price.

BAYN has been the subject of a number of other reports. JPMorgan Chase & Co. set a €120.00 ($139.53) target price on shares of Bayer and gave the stock a “buy” rating in a research note on Thursday, June 21st. Sanford C. Bernstein set a €115.00 ($133.72) target price on shares of Bayer and gave the stock a “buy” rating in a research note on Wednesday, September 5th. Cfra set a €100.00 ($116.28) target price on shares of Bayer and gave the stock a “buy” rating in a research note on Tuesday, August 14th. Goldman Sachs Group set a €111.00 ($129.07) target price on shares of Bayer and gave the stock a “buy” rating in a research note on Thursday. Finally, Independent Research set a €85.00 ($98.84) target price on shares of Bayer and gave the stock a “neutral” rating in a research note on Wednesday, September 5th. Seven analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of €98.80 ($114.88).

Shares of FRA BAYN opened at €76.10 ($88.49) on Thursday. Bayer has a 1-year low of €91.58 ($106.49) and a 1-year high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Featured Article: Why do company’s buyback their stock?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply